SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 135 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $117,473,830 | -12.8% | 5,722,057 | +1.1% | 9.06% | -35.7% |
| Q1 2024 | $134,708,000 | +10.1% | 5,660,000 | 0.0% | 14.10% | +4.0% |
| Q4 2023 | $122,312,600 | +110.6% | 5,660,000 | +41.5% | 13.55% | +42.6% |
| Q3 2023 | $58,080,000 | -14.9% | 4,000,000 | +22.6% | 9.50% | +1.2% |
| Q2 2023 | $68,273,744 | +0.8% | 3,262,004 | +1.7% | 9.39% | +7.4% |
| Q1 2023 | $67,710,424 | +3.9% | 3,205,986 | +25.2% | 8.74% | -12.6% |
| Q4 2022 | $65,182,209 | +19.3% | 2,561,187 | +12.7% | 10.00% | -13.1% |
| Q3 2022 | $54,618,000 | +13.0% | 2,272,915 | -9.5% | 11.51% | -6.8% |
| Q2 2022 | $48,335,000 | +43.9% | 2,512,240 | +30.0% | 12.34% | +13.3% |
| Q1 2022 | $33,592,000 | +60.5% | 1,932,800 | +102.1% | 10.90% | -2.6% |
| Q4 2021 | $20,930,000 | – | 956,165 | – | 11.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
| Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
| Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
| BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
| FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
| Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
| Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
| PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |